Education
About Us
Working with TipRanks
Follow Us
Optimizerx Corporation (OPRX)
NASDAQ:OPRX
OPRX Stock Chart & Stats
$7.39
-$1.11(-19.07%)
At close: 4:00 PM EST
$7.39
-$1.11(-19.07%)
Day’s Range― - ―
52-Week Range$3.99 - $22.25
Previous CloseN/A
Volume200.46K
Average Volume (3M)376.17K
Market Cap
$137.75M
Enterprise Value$146.84M
Total Cash (Recent Filing)$19.52M
Total Debt (Recent Filing)$28.61M
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Mar 05, 2026EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding18,640,652
10 Day Avg. Volume376,607
30 Day Avg. Volume376,172
Financial Highlights & Ratios
PEG Ratio-0.65
Price to Book (P/B)0.76
Price to Sales (P/S)0.97
P/FCF Ratio18.61
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue1.34
Enterprise Value/Gross Profit2.05
Enterprise Value/Ebitda12.76
Forecast
1Y Price Target
$22.50Price Target Upside204.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.86
Revenue Forecast (FY)$121.63M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins above 65% indicate a scalable, high-margin platform business with a favorable cost base. Persistent margin strength supports profitability as revenue grows, enabling reinvestment in product development and sales without eroding unit economics over the medium term.
Low Financial LeverageVery low leverage gives the company financial flexibility to fund growth, withstand demand shocks, and accelerate strategic debt paydown without stressing liquidity. A conservative balance sheet reduces default risk and preserves capacity for M&A or product investment over 2–6 months.
Improving Cash GenerationMeaningful FCF growth and near-parity of free cash flow to net income show improved cash conversion from operations. Durable cash generation supports debt reduction, working capital needs, and reinvestment in the platform, strengthening long-term operational resilience.
Bears Say
Minimal Net ProfitabilityAn almost zero net margin signals limited bottom-line conversion despite healthy gross margins, leaving little cushion for shocks or sustained investments. Structural factors like SG&A and variable comp can keep net profits muted, constraining free cash build and shareholder returns.
Customer ConcentrationHeavy revenue concentration in a handful of large customers increases exposure to contract loss or pricing pressure, reducing revenue predictability. Over a multi-quarter horizon, this concentration can amplify volatility in bookings and weaken negotiating leverage with dominant clients.
Rising Operating ExpensesHigher variable compensation tied to performance, if persistent, raises operating leverage and can erode operating margins as revenue growth moderates. Structurally elevated OPEX reduces the company's ability to convert higher gross margins into sustainable net profits and free cash flow.
OptimizeRx News
OPRX FAQ
What was Optimizerx Corporation’s price range in the past 12 months?
Optimizerx Corporation lowest stock price was $3.99 and its highest was $22.25 in the past 12 months.
What is Optimizerx Corporation’s market cap?
Optimizerx Corporation’s market cap is $137.75M.
When is Optimizerx Corporation’s upcoming earnings report date?
Optimizerx Corporation’s upcoming earnings report date is Mar 05, 2026 which is in 2 days.
How were Optimizerx Corporation’s earnings last quarter?
Optimizerx Corporation released its earnings results on Nov 06, 2025. The company reported $0.2 earnings per share for the quarter, beating the consensus estimate of $0.037 by $0.163.
Is Optimizerx Corporation overvalued?
According to Wall Street analysts Optimizerx Corporation’s price is currently Undervalued.
Does Optimizerx Corporation pay dividends?
Optimizerx Corporation does not currently pay dividends.
What is Optimizerx Corporation’s EPS estimate?
Optimizerx Corporation’s EPS estimate is 0.22.
How many shares outstanding does Optimizerx Corporation have?
Optimizerx Corporation has 18,640,652 shares outstanding.
What happened to Optimizerx Corporation’s price movement after its last earnings report?
Optimizerx Corporation reported an EPS of $0.2 in its last earnings report, beating expectations of $0.037. Following the earnings report the stock price went down -17.371%.
Which hedge fund is a major shareholder of Optimizerx Corporation?
Currently, no hedge funds are holding shares in OPRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OptimizeRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.50 (204.47% Upside)
$22.50 (204.47% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 4.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
42.66%
12-Months-Change
Fundamentals
Return on Equity
0.03%
Trailing 12-Months
Asset Growth
3.10%
Trailing 12-Months
Company Description
Optimizerx Corporation
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
OPRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance in Q3 with significant revenue and EBITDA growth, increased guidance for the current and following fiscal year, and strategic debt reduction. Despite these achievements, expectations for Q4 are conservative, and operating expenses have increased due to higher variable compensation. Overall, the sentiment is positive, with a focus on continued growth and operational excellence.View all OPRX earnings summariesOPRX Stock 12 Month Forecast
Average Price Target
$22.50
▲(204.47% Upside)
Technical Analysis
Ownership Overview
9.72% Insiders
16.15% Mutual Funds
23.01% Other Institutional Investors
40.65% Public Companies and
Individual Investors